MedPath

Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS

Completed
Conditions
Parkinson's Disease With Deep Brain Stimulation
Registration Number
NCT02080572
Lead Sponsor
Great Lakes NeuroTechnologies Inc.
Brief Summary

Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are made in the clinic. This study aims to quantitatively evaluate the effects of turning off deep brain stimulation on lower extremity and gait function over three hours. This study will provide vital information about our patient worn system's ability to detect changes in lower impairment over time, which could be used to assist with DBS tuning for the lower extremities and gait in the future.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Diagnosis of idiopathic Parkinson's disease
  • Age > 21
  • Underwent DBS surgery targeting the subthalamic nucleus (STN)
  • Bilateral or midline involvement when "off" DBS/medication state
  • Clinical history of gait impairment or freezing of gait
Exclusion Criteria
  • "Parkinson's plus" syndrome, secondary, or atypical Parkinson's disease
  • Underwent DBS surgery targeting the ventral intermediate (VIM)
  • Unable to walk independent of a wheelchair (use of assistive devices, like a cane, is okay for this study)
  • Dementia (determined by a neuropsychological assessment).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of DBS cessation on motor function over timeAll data will be collected within a single session not to exceed 4 hours. All data will be analyzed within one month of study completion.

Motor function evaluations (movement speed and magnitude) will be collected at various time points after DBS cessation. The effects over time will be examined.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University Hospitals of Case Western

🇺🇸

Cleveland, Ohio, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath